Titre : Tumeurs de l'abdomen

Tumeurs de l'abdomen : Questions médicales fréquentes

{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Tumeurs de l'abdomen : Questions médicales les plus fréquentes", "headline": "Tumeurs de l'abdomen : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Tumeurs de l'abdomen : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-09", "dateModified": "2025-04-04", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Tumeurs de l'abdomen" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Tumeurs par siège", "url": "https://questionsmedicales.fr/mesh/D009371", "about": { "@type": "MedicalCondition", "name": "Tumeurs par siège", "code": { "@type": "MedicalCode", "code": "D009371", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C04.588" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Tumeurs du rétropéritoine", "alternateName": "Retroperitoneal Neoplasms", "url": "https://questionsmedicales.fr/mesh/D012186", "about": { "@type": "MedicalCondition", "name": "Tumeurs du rétropéritoine", "code": { "@type": "MedicalCode", "code": "D012186", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C04.588.033.731" } } }, { "@type": "MedicalWebPage", "name": "Nodule de Soeur Marie-Joseph", "alternateName": "Sister Mary Joseph's Nodule", "url": "https://questionsmedicales.fr/mesh/D058288", "about": { "@type": "MedicalCondition", "name": "Nodule de Soeur Marie-Joseph", "code": { "@type": "MedicalCode", "code": "D058288", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C04.588.033.740" } } } ], "about": { "@type": "MedicalCondition", "name": "Tumeurs de l'abdomen", "alternateName": "Abdominal Neoplasms", "code": { "@type": "MedicalCode", "code": "D000008", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Robert Stoehr", "url": "https://questionsmedicales.fr/author/Robert%20Stoehr", "affiliation": { "@type": "Organization", "name": "Institute of Pathology, University Hospital Erlangen (UKER), Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany." } }, { "@type": "Person", "name": "Abbas Agaimy", "url": "https://questionsmedicales.fr/author/Abbas%20Agaimy", "affiliation": { "@type": "Organization", "name": "Institute of Pathology, University Hospital Erlangen (UKER), Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany. abbas.agaimy@uk-erlangen.de." } }, { "@type": "Person", "name": "Naseema Gangat", "url": "https://questionsmedicales.fr/author/Naseema%20Gangat", "affiliation": { "@type": "Organization", "name": "Mayo Clinic, Rochester, MN, USA." } }, { "@type": "Person", "name": "Paul H Sugarbaker", "url": "https://questionsmedicales.fr/author/Paul%20H%20Sugarbaker", "affiliation": { "@type": "Organization", "name": "Center for Gastrointestinal Malignancies, MedStar Washington Hospital Center, Washington, District of Columbia, USA." } }, { "@type": "Person", "name": "David Chang", "url": "https://questionsmedicales.fr/author/David%20Chang", "affiliation": { "@type": "Organization", "name": "Westat, Rockville, Maryland, USA." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Imaging of pediatric abdominal soft tissue tumors: A COG Diagnostic Imaging Committee/SPR Oncology Committee White Paper.", "datePublished": "2023-04-19", "url": "https://questionsmedicales.fr/article/37073573", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/pbc.30341" } }, { "@type": "ScholarlyArticle", "name": "Intrafraction organ movement in adaptive MR-guided radiotherapy of abdominal lesions - dosimetric impact and how to detect its extent in advance.", "datePublished": "2024-06-25", "url": "https://questionsmedicales.fr/article/38918828", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s13014-024-02466-x" } }, { "@type": "ScholarlyArticle", "name": "Risk factors and effect of postoperative delirium on adverse surgical outcomes in older adults after elective abdominal cancer surgery in Taiwan.", "datePublished": "2022-08-28", "url": "https://questionsmedicales.fr/article/36041906", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.asjsur.2022.08.079" } }, { "@type": "ScholarlyArticle", "name": "Accuracy of abdominal organ motion estimation in radiotherapy using the right hemidiaphragm top as a surrogate during prolonged breath-holds quantified with MRI.", "datePublished": "2023-04-14", "url": "https://questionsmedicales.fr/article/37009641", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/mp.16403" } }, { "@type": "ScholarlyArticle", "name": "The efficacy of the American College of Surgeons Surgical Risk Calculator in the prediction of postoperative complications in oncogeriatric patients after curative surgery for abdominal tumors.", "datePublished": "2022-08-04", "url": "https://questionsmedicales.fr/article/35924711", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/jso.27046" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Tumeurs", "item": "https://questionsmedicales.fr/mesh/D009369" }, { "@type": "ListItem", "position": 3, "name": "Tumeurs par siège", "item": "https://questionsmedicales.fr/mesh/D009371" }, { "@type": "ListItem", "position": 4, "name": "Tumeurs de l'abdomen", "item": "https://questionsmedicales.fr/mesh/D000008" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Tumeurs de l'abdomen - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Tumeurs de l'abdomen", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-04-30", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Tumeurs de l'abdomen", "description": "Comment diagnostiquer une tumeur abdominale ?\nQuels tests sanguins sont utiles ?\nQuels symptômes indiquent une tumeur abdominale ?\nQuelle imagerie est la plus précise ?\nQuand faire une échographie abdominale ?", "url": "https://questionsmedicales.fr/mesh/D000008?page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Tumeurs de l'abdomen", "description": "Quels sont les symptômes courants des tumeurs abdominales ?\nLa jaunisse est-elle un symptôme ?\nPeut-on avoir des symptômes sans tumeur visible ?\nLes tumeurs abdominales causent-elles des vomissements ?\nComment la fatigue est-elle liée aux tumeurs ?", "url": "https://questionsmedicales.fr/mesh/D000008?page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Tumeurs de l'abdomen", "description": "Peut-on prévenir les tumeurs abdominales ?\nLe tabagisme augmente-t-il le risque ?\nL'alcool est-il un facteur de risque ?\nLes infections peuvent-elles causer des tumeurs ?\nLe surpoids est-il un risque ?", "url": "https://questionsmedicales.fr/mesh/D000008?page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Tumeurs de l'abdomen", "description": "Quels sont les traitements des tumeurs abdominales ?\nQuand est la chirurgie nécessaire ?\nLa chimiothérapie est-elle efficace ?\nQuels effets secondaires des traitements ?\nLa radiothérapie est-elle utilisée ?", "url": "https://questionsmedicales.fr/mesh/D000008?page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Tumeurs de l'abdomen", "description": "Quelles complications peuvent survenir ?\nLes tumeurs peuvent-elles causer des douleurs chroniques ?\nComment les tumeurs affectent-elles la digestion ?\nLes tumeurs abdominales peuvent-elles causer des infections ?\nQuelles sont les conséquences d'une métastase ?", "url": "https://questionsmedicales.fr/mesh/D000008?page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Tumeurs de l'abdomen", "description": "Quels sont les principaux facteurs de risque ?\nLes antécédents médicaux influencent-ils le risque ?\nL'exposition à des produits chimiques est-elle un risque ?\nLe stress a-t-il un impact sur le risque ?\nLes maladies génétiques augmentent-elles le risque ?", "url": "https://questionsmedicales.fr/mesh/D000008?page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une tumeur abdominale ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic se fait par imagerie (IRM, scanner) et biopsie." } }, { "@type": "Question", "name": "Quels tests sanguins sont utiles ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les marqueurs tumoraux comme l'AFP et le CA 19-9 peuvent aider au diagnostic." } }, { "@type": "Question", "name": "Quels symptômes indiquent une tumeur abdominale ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Douleurs abdominales, perte de poids, nausées et changements d'appétit." } }, { "@type": "Question", "name": "Quelle imagerie est la plus précise ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "L'IRM est souvent plus précise pour visualiser les tissus mous." } }, { "@type": "Question", "name": "Quand faire une échographie abdominale ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'échographie est utile pour évaluer des masses abdominales suspectes." } }, { "@type": "Question", "name": "Quels sont les symptômes courants des tumeurs abdominales ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent douleurs, ballonnements, nausées et perte d'appétit." } }, { "@type": "Question", "name": "La jaunisse est-elle un symptôme ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la jaunisse peut indiquer une tumeur au foie ou des voies biliaires." } }, { "@type": "Question", "name": "Peut-on avoir des symptômes sans tumeur visible ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des symptômes peuvent apparaître même sans tumeur détectable." } }, { "@type": "Question", "name": "Les tumeurs abdominales causent-elles des vomissements ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les vomissements peuvent survenir en raison de l'obstruction intestinale." } }, { "@type": "Question", "name": "Comment la fatigue est-elle liée aux tumeurs ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "La fatigue peut résulter de la maladie, des traitements ou de l'anémie." } }, { "@type": "Question", "name": "Peut-on prévenir les tumeurs abdominales ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Certaines mesures comme une alimentation saine et l'exercice peuvent réduire le risque." } }, { "@type": "Question", "name": "Le tabagisme augmente-t-il le risque ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme est un facteur de risque pour plusieurs types de tumeurs abdominales." } }, { "@type": "Question", "name": "L'alcool est-il un facteur de risque ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une consommation excessive d'alcool peut augmenter le risque de tumeurs hépatiques." } }, { "@type": "Question", "name": "Les infections peuvent-elles causer des tumeurs ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Certaines infections, comme l'hépatite B, peuvent augmenter le risque de cancer du foie." } }, { "@type": "Question", "name": "Le surpoids est-il un risque ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'obésité est associée à un risque accru de plusieurs tumeurs abdominales." } }, { "@type": "Question", "name": "Quels sont les traitements des tumeurs abdominales ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent chirurgie, chimiothérapie et radiothérapie." } }, { "@type": "Question", "name": "Quand est la chirurgie nécessaire ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "La chirurgie est souvent nécessaire pour retirer la tumeur et les tissus environnants." } }, { "@type": "Question", "name": "La chimiothérapie est-elle efficace ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut réduire la taille des tumeurs et prévenir les récidives." } }, { "@type": "Question", "name": "Quels effets secondaires des traitements ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Les effets secondaires incluent nausées, fatigue, et perte de cheveux." } }, { "@type": "Question", "name": "La radiothérapie est-elle utilisée ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle est utilisée pour traiter certaines tumeurs abdominales localisées." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent la métastase, l'obstruction intestinale et l'hémorragie." } }, { "@type": "Question", "name": "Les tumeurs peuvent-elles causer des douleurs chroniques ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les tumeurs peuvent provoquer des douleurs chroniques en raison de leur taille ou de leur emplacement." } }, { "@type": "Question", "name": "Comment les tumeurs affectent-elles la digestion ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent provoquer des obstructions, entraînant des problèmes digestifs." } }, { "@type": "Question", "name": "Les tumeurs abdominales peuvent-elles causer des infections ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les tumeurs peuvent affaiblir le système immunitaire, augmentant le risque d'infections." } }, { "@type": "Question", "name": "Quelles sont les conséquences d'une métastase ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Les métastases peuvent affecter d'autres organes, compliquant le traitement et le pronostic." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'âge, le tabagisme, l'alcool et des antécédents familiaux." } }, { "@type": "Question", "name": "Les antécédents médicaux influencent-ils le risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents de maladies comme la colite peuvent augmenter le risque." } }, { "@type": "Question", "name": "L'exposition à des produits chimiques est-elle un risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exposition à certains produits chimiques peut augmenter le risque de cancer abdominal." } }, { "@type": "Question", "name": "Le stress a-t-il un impact sur le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Le stress chronique peut influencer la santé globale, mais son lien direct est moins clair." } }, { "@type": "Question", "name": "Les maladies génétiques augmentent-elles le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines maladies génétiques comme le syndrome de Lynch augmentent le risque." } } ] } ] }

Sources (8841 au total)

Intrafraction organ movement in adaptive MR-guided radiotherapy of abdominal lesions - dosimetric impact and how to detect its extent in advance.

Magnetic resonance guided radiotherapy (MRgRT) allows daily adaptation of treatment plans to compensate for positional changes of target volumes and organs at risk (OARs). However, current adaptation ... Twenty patients receiving adaptive MRgRT for treatment of abdominal lesions were retrospectively analyzed. Magnetic resonance (MR) images acquired at the start of adaptation and immediately before irr... A significant increase in dose constraint violations was observed from adapted (6.9%) to pre-irradiation (30.2%) dose distributions. Overall, OAR dose increased significantly by 4.3% due to intrafract... Intrafractional organ movement can impact dose distributions and lead to violations of OAR tolerance doses, which impairs the benefit of daily on-table plan adaptation. By application of simulation im...

Risk factors and effect of postoperative delirium on adverse surgical outcomes in older adults after elective abdominal cancer surgery in Taiwan.

Postoperative delirium (POD) is a common complication in older adults, with unknown epidemiology and effects on surgical outcomes in Asian geriatric cancer patients. This study evaluated incidence, ri... Overall, 345 patients aged ≥65 years who underwent elective abdominal cancer surgery at a medical center in Taiwan were prospectively enrolled. Delirium was assessed daily using the Confusion Assessme... POD occurred in 19 (5.5%) of the 345 patients. Age ≥73 years, Charlson comorbidity index ≥3, and operative time >428 min were independent predictors for POD occurrence. Patients presenting with one, t... POD occurrence was significantly associated with adverse surgical outcomes in geriatric patients undergoing elective abdominal cancer surgery, highlighting the importance of early POD identification i...

Accuracy of abdominal organ motion estimation in radiotherapy using the right hemidiaphragm top as a surrogate during prolonged breath-holds quantified with MRI.

Respiratory motion presents a challenge in radiotherapy of thoracic and upper abdominal tumors. Techniques to account for respiratory motion include tracking. Using magnetic resonance imaging (MRI) gu... The aim of this study was to quantify the error when using the right hemidiaphragm top (RHT) as surrogate for abdominal organ motion during prolonged breath-holds (PBH) for possible application in rad... Fifteen healthy volunteers were trained to perform PBHs in two subsequent MRI sessions (PBH-MRI1 and PBH-MRI2). From each MRI acquisition, we selected seven images (dynamics) to determine organ displa... The linear relationships were confirmed by the high R... The RHT could serve as an accurate surrogate for abdominal organ motion during radiation treatments, for example, in tracking, provided the error of the RHT as motion surrogate is taken into account i... The study was registered in the Netherlands Trial Register (NL7603)....

The efficacy of the American College of Surgeons Surgical Risk Calculator in the prediction of postoperative complications in oncogeriatric patients after curative surgery for abdominal tumors.

The American College of Surgeons (ACS) has developed a Surgical Risk Calculator (SRC) to predict postoperative surgical complications. No studies have reported the performance of the ACS-SRC in oncoge... This is a retrospective study including 136 patients who underwent elective abdominal oncological surgery, between 2017 and 2019, at our institution. Postoperative complications were classified accord... Discrimination was adequate with AUC of 0.7113 (95% confidence interval [CI]: 1.062-1.202, p = 0.0001; Brier 0.198) for serious complications and 0.7230 (95% CI: 1.101-1.756, p = 0.0057; Brier 0.099) ... The ACS-SRC is an adequate predictor for serious complications and pneumonia in oncogeriatric patients treated surgically for abdominal cancer. However, the predictive power of the calculator appears ...

Real-time motion monitoring using orthogonal cine MRI during MR-guided adaptive radiation therapy for abdominal tumors on 1.5T MR-Linac.

Real-time motion monitoring (RTMM) is necessary for accurate motion management of intrafraction motions during radiation therapy (RT).... Building upon a previous study, this work develops and tests an improved RTMM technique based on real-time orthogonal cine magnetic resonance imaging (MRI) acquired during magnetic resonance-guided ad... A motion monitoring research package (MMRP) was developed and tested for RTMM based on template rigid registration between beam-on real-time orthogonal cine MRI and pre-beam daily reference 3D-MRI (ba... The mean (range) centroid motions for the 13 abdominal tumor cases were 7.69 (4.71-11.15), 1.73 (0.81-3.05), and 2.71 (1.45-3.93) mm with an overall accuracy of <2 mm in the superior-inferior (SI), th... We have successfully developed and tested the use of a template-based registration method for an accurate RTMM of abdominal targets during MRgART on a 1.5T MR-Linac without using injected contrast age...

Association of health literacy with short-term postoperative outcomes in older adult patients with abdominal tumors undergoing surgery and perioperative rehabilitation program: A prospective cohort study.

Low health literacy (HL) is associated with poor surgical outcomes in patients with abdominal tumors, despite enhanced recovery programs. However, the relationship between HL and postoperative outcome... The prospective cohort study was conducted from April 2020 to December 2021 in a single acute care hospital in Akita City, Japan. Out of 112 consecutive older adults with abdominal tumors referred to ... Of the 97 patients (36 [37.1%] women, mean [standard deviation] age 74.4 [6.3] years), 42 (43.3%) reported low HL. At baseline, patients with low HL exhibited worse EQ-5D-5L scores (P = .001), EQ-VAS ... There appeared to be no apparent associations of HL with surgical outcomes in patients with abdominal tumors receiving PRPs. Thus, HL might not be a crucial predictor of surgical outcomes when combine...

Efficacy and safety of remimazolam for procedural sedation during ultrasound-guided transversus abdominis plane block and rectus sheath block in patients undergoing abdominal tumor surgery: a single-center randomized controlled trial.

To explore the efficacy and safety of remimazolam for procedural sedation during ultrasound-guided nerve block administration in patients undergoing abdominal tumor surgery, in order to improve and op... The enrolled patients were randomly divided into three groups: 50 patients in the remimazolam group (R group), 50 patients in the dexmedetomidine group (D group), and 50 patients in the midazolam grou... Compared with the control groups (midazolam and dexmedetomidine groups), the Narcotrend index and MOAA/S decreased more in the remimazolam group (P < 0.01). Compared with the control groups, the incid... Remimazolam can be used safely for procedural sedation during ultrasound-guided nerve block administration in patients undergoing abdominal tumor surgery. The sedation effect is better than that with ... This study was approved by the Ethics Committee of Anhui Provincial Cancer Hospital (Ethical Review 2021, No. 23) and registered at https://www.chictr.org.cn (ChiCTR2000035388). The pre-registration t...

[Surgical treatment for recurrent intra-abdominal mucinous neoplasms].

The gold standard in the treatment of mucinous intra-abdominal neoplasms is cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC). Despite complete cytoreduction ... A search and analysis of the current literature were carried out.... There is still controversy regarding the best treatment strategy for patients with recurrent pseudomyxoma peritonei (PMP) after CRS and HIPEC. The clinical management of these patients depends on many... Repeated complete cytoreduction of recurrent PMP can result in long-term survival. Tumor debulking surgery may be particularly beneficial for symptomatic patients....

Palliation of mucinous appendiceal neoplasms with peritoneal metastases with total abdominal colectomy.

Incomplete cytoreduction for mucinous appendiceal neoplasms is often required to temporarily alleviate symptoms. The surgical technology for this intervention may be complex and result in extensive mo... A database was used to identify patients who had palliative surgery that included total abdominal colectomy (TAC). Clinical- and treatment-related variables were assessed for their impact on overall s... Seventy-eight patients had an incomplete cytoreductive surgery (CRS) that included a TAC. The median survival was 2.5 years and the median follow-up was 2 years. Patients with symptoms of abdominal di... TAC with end ileostomy was used as a treatment option to provide palliation of patients having an incomplete CRS for appendiceal mucinous neoplasms. With LAMN or MACA-Int, median survival was 5.0 year...